Back to News
Market Impact: 0.55
Apollo Global in talks to acquire J&J's orthopedics unit, Bloomberg News reports
Source: reuters.com
M&A & RestructuringHealthcare & BiotechPrivate Markets & Venture
Apollo Global Management is reportedly in discussions to acquire Johnson & Johnson's orthopedics unit in a transaction that could value the business at nearly $20 billion. If completed, the deal would represent a major private-equity healthcare carve-out and could materially reshape J&J's portfolio.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
APO0.35
JNJ0.20
More News
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Apollo to buy nearly 10% stake in Abu Dhabi-backed alternative asset manager Mubadala Capital
- Pimco buys $4 billion of SpaceX AI debt package led by Apollo
- Saudi Arabia’s Wall Street Appeal Dims; Oman Scores Wins; Abu Dhabi- Apollo Deal
- Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs